Novartis AG
SIX:NOVN
Novartis AG
SIX:NOVN
Price:
89.72 CHF
1.84%
Market Closed
Updated:
May 7, 2024
Novartis AG
Net Income (Common)
|
Novartis AG
Net Income (Common) Peer Comparison
Comparables:
NLSP
ROG
S
SDZ
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Novartis AG
SIX:NOVN
|
Net Income (Common)
$14.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Net Income (Common)
-$16.5m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Roche Holding AG
SIX:ROG
|
Net Income (Common)
CHf11.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Net Income (Common)
$848m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novartis AG's Net Income (Common)?
Net Income (Common)
14.9B
USD
14.9B
USD
Based on the financial report for Dec 31, 2023, Novartis AG's Net Income (Common) amounts to 14.9B USD.
What is Novartis AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
5%
5%
Over the last year, the Net Income (Common) growth was 114%. The average annual Net Income (Common) growth rates for Novartis AG have been 23% over the past three years , 3% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
